טוען...
Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?
Hepatocellular carcinoma is the fastest growing cause of cancer related death globally. Sorafenib, a multi-targeted kinase inhibitor, is the only drug proven to improve outcomes in patients with advanced disease offering modest survival benefit. Although comprehensive genomic mapping has improved un...
שמור ב:
| הוצא לאור ב: | World J Gastrointest Oncol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Inc
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4753168/ https://ncbi.nlm.nih.gov/pubmed/26909132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v8.i2.173 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|